Document is current
Any future updates will be listed below
-
Authors
Deandrea, Silvia
Mantellini, Paola https://orcid.org/0000-0003-4114-4011
Rossi, Paolo Giorgi
Vecchio, Riccardo
Capobussi, Matteo
Rosselli Del Turco, Marco
Pietribiasi, Francesca
Bucchi, Lauro
Senore, Carlo
Sardanelli, Francesco
Battisti, Francesca
Giordano, Livia
Paci, Eugenio
Parmelli, Elena
Saguatti, Gianni
Zappa, Marco
,
Cannatà, Vittorio
Castellano, Isabella
Dardanoni, Gabriella
Francolini, Giulio
Gori, Stefania
Magliocca, Carlo
Montemezzi, Stefania
Pacifici, Stefano
Torri, Emanuele
Trianni, Annalisa
Ambrogetti, Daniela
Angiolini, Catia
Bellardini, Paola
Bonifacino, Adriana
Bonvicini, Laura
Brancato, Beniamino
Bucchi, Lauro
Calabrese, Massimo
Campa, Stefano
Carnesciali, Eva
Caumo, Francesca
Deandrea, Silvia
Degrassi, Flori
Fava, Valeria
Giordano, Livia
Rossi, Paolo Giorgi
Golinelli, Paola
Meattini, Icro
Moschetta, Marco
Mosconi, Paola
Paci, Eugenio
Pau, Loredana
Pedilarco, Stella
Pietribiasi, Francesca
Rosselli Del Turco, Marco
Salgarello, Marzia
Santucci, Gioele
Sassoli de Bianchi, Priscilla
Satolli, Roberto
Scatena, Cristian
Senore, Carlo
Serra, Margherita
Taffurelli, Mario
Zappa, Marco
Pattacini, Pierpaolo
Segnan, Nereo
- License Information
-
More Information
Article History
Received: 20 May 2024
Accepted: 5 October 2024
First Online: 26 October 2024
Declarations
:
: Silvia Deandrea is the President of the Italian Mammography Screening Group; Marco Rosselli Del Turco was a medical consultant for senology at FORA s.p.a. Paolo Giorgi Rossi is a member of the panel that developed the European guidelines on breast cancer screening and diagnosis, referred document for the ADOLOPMENT process; Livia Giordano is a member of the panel that developed the European guidelines on breast cancer screening and diagnosis, referred document for the ADOLOPMENT process; Elena Parmelli was a contract staff member at the Joint Research Centre (JRC) of the European Commission, Ispra, VA (Italy); Cannatà Vittorio has been Vice-President of the Italian Association of Medical Physics (AIFM); Isabella Castellano has been professional consultant for symposium “Choosing the best therapy in ER + /HER2- breast cancer” (Token of attendance at the National Congress of Anatomic Pathology, October 2019), Myriad Genetics, s.r.l.; Stefano Pacifici is the President of the Italian Association of Senology Radiographers (AITeRS); Trianni Annalisa is a member of the Italian Association of Medical Physics (AIFM); Paola Golinelli was reimbursed for participation in the European Federation of Organization for Medical Physics (EFOMP) Working Group on mammographic tomosynthesis equipment. Pierpaolo Pattacini received a software by I-CAD. The other authors have no relevant financial or non-financial interest to disclose. Competing interests: All panellists were required to disclose all financial, non-financial, personal, and institutional interests relevant to the scope of the guidelines by completing a standardized form, following SNLG guidance. The Scientific Committee (SC) assessed each individual interest, and ultimately, no panellist was excluded from the voting procedures. This policy was upheld throughout the entire process, including the selection of panel members, the generation and prioritization of research questions, and participation in the formulation of recommendations. The SC consistently monitored the declaration of conflicts of interest (COI).
: Ethical approval was not necessary for this kind of scientific work.
: Not applicable.
